In recent years scientific literature has seen an increase in publications describing new transgenic applications. Although technically-sound, these promising developments might not necessarily translate into products available to the consumer. This article highlights the impact of external factors on the commercial viability of Genetically Modified (GM) animals in the pharmaceutical and food s...

Page Summary

The present paper reports medicinal properties of 69 plants of Dumka forest division of Dumka district of Bihar. The information is gathered from the tribals and local physicians inhabiting the forest.

Production and processing of genetically modified organisms (GMO) in line with the European food safety and labelling regulations lead to an elevated risk of unintentional GMO contamination in food producing and processing companies. For these companies GMO contamination can lead to extensive losses such as decreased product value, recall expenses or decreased brand equity. The question that oc...

The release of the Final Guidance from the US Food and Drug Administration on the commercialization of genetically engineered animals has sparked renewed discussion over the ethical, consumer, and regulatory implications of transgenesis in animal agriculture. Animal welfare critiques have focused on unexpected phenotypic effects in animals used in transgenic research, rather than on the health ...

MicroRNAs (miRNAs) have been widely demonstrated to play fundamental roles in gene regulation in most eukaryotes. To date, there has been no study describing the miRNA composition in genetically modified organisms (GMOs). In this study, small RNAs from dry seeds of two GM soybean lines and their parental cultivars were investigated using deep sequencing technology and bioinformatic approaches. ...